P01: Impact of DNA Contaminants on Next-Generation Sequencing Data Quality, Presented by Lauren S., Beckman Coulter Life Sciences

P02: Integration of the 31-Gene Expression Profile Test with Clinicopathologic Features (i31-GEP) to Assess Sentinel Lymph Node Positivity Risk in Patients with Cutaneous Melanoma, Presented by Olga Z., Castle Biosciences, Inc

P03: Development of a Novel IVD Test for the Prediction of Biological Therapy Responsiveness in Rheumatoid Arthritis, Presented by Laszlo S., EGIS Pharmaceuticals PLC

P04: peakPCR: A Portable Platform for Rapid PCR Diagnostics in Remote and Resource-Limited Settings, Presented by Philippe B., ETH Zurich

P05: Non-Invasive Detection of Bladder Cancer Using Novel Physical Markers, Presented by Phuong P., Tufts University

P06: Serial Monitoring of Precision Oncology Genomic Alterations in Circulating Tumor Cells of ER Positive/HER2 Negative Advanced Breast Cancer, Presented by Andi C., University of Michigan Medical School

P07: Protein Interfaces for Biosensing, Presented by Felix F., University of Oxford

P08: POC Molecular Testing Platform for COVID Testing and Beyond, Presented by Ming T., Wainamics, Inc. & Nancy S., AmplifiDx, Inc.

P09: Flexible Polymeric Substrates as Versatile Platforms for Rapid POCT Immunodiagnostics, Presented by Marcin D., Warsaw University of Technology

P10: A Comparison of Cyclo Olefin Polymer with Glass and Other Plastics for the Construction of Molecular Diagnostic Consumable Devices, Presented by Larry A., Zeon Specialty Materials

P11: Evaluation of a Plasma Separation Device for Use in Molecular Detection Applications, Presented by Mahmoud Z., GattaCo, Inc.